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Abstract
Background: Identification of differentially expressed genes is a typical objective when analyzing
gene expression data. Recently, Bayesian hierarchical models have become increasingly popular to
solve this type of problems. These models show good performance in accommodating noise,
variability and low replication of microarray data. However, the correlation between different
fluorescent signals measured from a gene spot is ignored, which can diversely affect the data
analysis step. In fact, the intensities of the two signals are significantly correlated across samples.
The larger the log-transformed intensities are, the smaller the correlation is.
Results:  Motivated by the complicated error relations in microarray data, we propose a
multivariate hierarchical Bayesian framework for data analysis in the replicated microarray
experiments. Gene expression data are modelled by a multivariate normal distribution,
parameterized by the corresponding mean vectors and covariance matrixes with a conjugate prior
distribution. Within the Bayesian framework, a generalized likelihood ratio test (GLRT) is also
developed to infer the gene expression patterns. Simulation studies show that the proposed
approach presents better operating characteristics and lower false discovery rate (FDR) than
existing methods, especially when the correlation coefficient is large. The approach is illustrated
with two examples of microarray analysis. The proposed method successfully detects significant
genes closely related to the experimental states, which are verified by the biological information.
Conclusions: The multivariate Bayesian model, compatible with the dependence between mean
and variance in the univariate Bayesian model, relaxes the constant coefficient of variation
assumption between measurements by adding a covariance structure. This model improves the
identification of differentially expressed genes significantly since the Bayesian model fit well with the
microarray data.
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Background
DNA microarrays offer a powerful and effective technol-
ogy to monitor the alterations of gene expression for thou-
sands of genes simultaneously. This technology has been
widely applied to the exploration of quantitative changes
in gene expression in a variety of areas including diseases
and toxicological studies [1-4]. One of the key tasks of
microarray analysis is to investigate the expression pat-
terns from the different experiment designs so that differ-
entially expressed (DE) genes can be identified [5,6].
In this paper, we consider the analysis of a two-color
cDNA microarray experiment. Briefly, mRNA contained
in each of two cell populations is extracted, reverse-tran-
scribed into cDNA, and labelled with either Cy3 (green)
or Cy5 (red) dyes. Cy3 and Cy5 preparations are com-
bined and deposited on the microarray, where labelled
molecules hybridize to the spots containing their comple-
mentary sequence. The amount of hybridization to each
spot is quantified by scanning the array with a laser beam
and observed the intensities of light emitted [7]. A pair of
measurements, separately for the two dyes, are observed
as xgi and ygi (g = 1,,N; i = 1,,n) for gene g on array i,
where N is the number of genes represented on the micro-
array and n is the number of replicated arrays.
Given the microarray expression data, a common task is to
determine which genes are differentially expressed under
the two conditions. There has been a considerable
amount of work in this area [8-26]. The simplest way to
ascertain a gene's differential expression is based on a fold
change criteria, defined by the log-ratio (log2(xgi/ygi)). The
straightforward fold-change method widely used by biol-
ogists takes into account only the genes whose fold
changes are more than 2-fold as differentially expressed
genes. The 2-fold rule is too simple to deal with the issues
raised by the complicated error in DNA microarray data
analysis [8-12].
Traditional statistical methods may not produce reliable
results when they are used directly to determine differen-
tially expressed genes. Firstly, it is common to have thou-
sands of genes on one chip with relatively few replications
in microarray experiments. Thus, the variance estimates of
gene expression data are often unreliable with the small
sample size. The common approach using t- or F-statistic
is not applicable since it strongly depends on the sample
size and normality of the expression data [8-10]. It is
known that microarray data may not follow a normal dis-
tribution or even be symmetrical and the sample size is
generally small [12-16]. Modified t-statistic is suggested
by adding a small constant to the gene-specific variance
estimate [17]. The method makes the gene-specific vari-
ance estimates shrink towards a common variance.
Recently, the hierarchical Bayesian models are employed
to variance regulation by estimating moderate variances
of individual genes [18-26]. The adjusted variances are
calculated with the weighted averages of the gene-specific
sample variances and pooled variances across all genes.
With the additional combination of variances, the per-
formance of these methods is improved significantly in
identifying the significance of gene expression.
Another common feature of microarray data is the distinc-
tive error structure with gene variances changing with the
expression levels in a nonlinear fashion [14,15]. Their
relations are shown with our experimental data in Figure
1. Some traditional methods are statistically inefficient
because of the significant violation from the general
assumptions. However, the Bayesian philosophy appears
to be suitable for this type of problems [18-26]. Instead of
the directly modelling the fluctuation of microarray data,
Bayesian models are characterized by mixing measure-
ments over a latent gene-specific component. A hierarchi-
cal gamma-gamma (GG) model is developed in [18] for
detecting changes of gene expression in a two-channel
cDNA microarray experiment. The model is extended to
replicated chips with multiple conditions using a hierar-
chical lognormal-normal (LNN) model [26]. Both of
them are based on the assumption of a constant coeffi-
cient of variation (CV) across genes. According to exten-
sive exploratory data analysis, however, we observe that
there are specific correlations between the pair of meas-
urements within each gene spot across samples. The cor-
relation pattern is presented in Figure 2.
Motivated by these error relations, we propose a novel
multivariate Bayesian framework for microarray analysis.
The multivariate Bayesian model, compatible with the
dependence between mean and variance in the univariate
Bayesian model, can relax the constant assumption
between measurements by adding a covariance structure.
Due to the computational complexity within the Bayesian
framework, we apply the modified generalized likelihood
ratio test (GLRT) proposed by Benjamini and Hochberg
[27,28] to detect gene expression patterns. When the
Bayesian model is in accordance with the microarray data,
the power of true identification of differentially expressed
genes can be improved substantially.
In this paper, we describe the multivariate Bayesian hier-
archical model for gene expression data analysis, and
present the generalized likelihood ratio test (GLRT) proce-
dures with the p-value adjustment to identify differen-
tially expressed genes. The sample size of microarray data
play an important role in replicated microarray experi-
ments. So in our simulation study, we first explore the
effect of the number of replications in our methodology
and suggest that the number of replicated chips is not less
than 4. We also compare our methods with existing ones,BMC Bioinformatics 2008, 9(Suppl 1):S9 http://www.biomedcentral.com/1471-2105/9/S1/S9
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such as fold change, modified t-test and LNN model. The
new methodology shows good performance based on
operating characteristics. In the analysis of the real micro-
array data, our method is proven to be powerful to iden-
tify more significant genes.
Results
Multivariate hierarchal Bayesian model and inference
Based on the LNN hierarchical model [26], we develop a
multivariate model to relax the constant CV assumption
between measurements by adding covariance. The model
is also compatible with the complicated structure of vari-
ance in microarray data. The model is first described in
this section, and then the GLRT is employed to infer the
expression pattern.
First, we consider the typical two-color microarray data xgi
and ygi (g = 1,,N; i = 1,,n) for gene g on array i, where
N is the number of genes represented on the microarray
and n is the number of replicated arrays. We denote the n
replicated pairs of expression levels of gene g  as  Zg =
(zg1,,zgn)', where zgi = (xgi, ygi)'. Firstly, zgi is assumed to
follow approximately a multivariate Gaussian distribu-
tion N2(zgi | μg, Σg) with a latent gene-specific expression
component π(μg, Σg). Thus, the likelihood of gene g is
written as
The Bayesian formulation requires a prior distribution
π(μg, Σg). For a normal distribution, several kinds of priors
for the mean and variance variables have been studied in
the literature, including the vague prior and natural con-
jugate prior [29]. For microarray data, the conjugate prior
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n
gg i g g
i
n
n
gg i g g g i ( ) ( | , ) ( ) exp ( )’ ( Zz z z =∑ = ∑ − − ∑
=
− − − ∏ μ μμ μ
1
1 2 2
1
2
π − −
⎧
⎨
⎪
⎩ ⎪
⎫
⎬
⎪
⎭ ⎪ ∑ μ μg
i
)
(1) Mean of log-transformed intensities v.s. correlation coeffi- cient Figure 2
Mean of log-transformed intensities v.s. correlation 
coefficient. The x-axis is the mean of log-transformed 
measurements over the replications and y-axis is the correla-
tion coefficient between the pair of measurements within a 
spot.
Robust locations v.s. scales of gene expression data Figure 1
Robust locations v.s. scales of gene expression data. The x-axis is the estimation of locations and y-axis is the estimation 
of scales. The left graph is plotted with the expression data of control groups and the right one is for the Cd toxic treatment 
(right) groups in Cd toxic microarray experiment.BMC Bioinformatics 2008, 9(Suppl 1):S9 http://www.biomedcentral.com/1471-2105/9/S1/S9
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is a suitable choice [18-22]. Indeed, not only their poste-
rior has the same functional form as the prior, but the con-
jugate prior also incorporates the inherent dependence
between the mean and the variance [26]. The multivariate
conjugate prior distribution π(μg, Σg) of Equation (1) is
composed of the probability distributions of μg | Σg fol-
lowing a multivariate normality and Σg  following an
inverse Wishart distribution (IW) as
in which α = {λ0, ν0, Λ0} contains the global hyperparam-
eters and   the gene-specific parame-
ters. Given the parameters, the conjugate prior
 is the following product
By the Bayes rule, the corresponding posterior distribu-
tion also has the same functional form as the prior
where
and  , the estimation of
mean expression of gene g over n replications. Obviously,
the posterior combines the information from the prior
and the data in a sensible way.
Since α and Θ are generally unknown, we estimate them
with maximum likelihood estimation (MLE). The likeli-
hood functions of gene g and over all genes are respec-
tively written as
and
The gene-specific parameters   are only related to Lg(α,
). Their optimal values might be obtained by solving
the equation
Therefore, Equation (4) can be rewritten by the Bayes rule
as
With Equations (1), (2), and (3), Equation (6) can be
explicitly expressed as
Finally, the following solutions are calculated as the esti-
mates of 
Given these estimates  , the global parameters   can be
estimated by maximizing the likelihood function in Equa-
tion (5).
Based on the proposed multivariate hierarchical model,
the GLRT, which is a generalization of the Neyman-Pear-
son test, can be used for the identification. In fact, the
identification between two cell populations is equivalent
to testing the following hypothesis,
Thus, the corresponding GLRT statistic for our hypothesis
can be defined as follows:
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Obviously, the denominator of Equation (8) is the maxi-
mization subject to   while the optimiza-
tion in the numerator is unconstrained. In fact, the
theoretical optimal estimates of   without constraint are
determined in Equation (7). Also the estimates with the
constraint can be found by solving
and the solutions are
It is proven that κg approximately follows the χ2 distribu-
tion with one degree of freedom on the null hypothesis
[28]. If κg is larger than some critical value κ of χ2(1), we
would not reject the alternative H1, that is to say, gene g
would be identified as DE gene, otherwise as an equiva-
lently expressed (EE) gene. However, it is essential to con-
trol some erroneous rejections and acceptances in testing
situation. In the context of microarray, the false discovery
rate (FDR) has emerged as a practical object to be control-
led in multiple testing [30,31]. The FDR is defined as the
expectation of type I errors among the rejected null hypo-
thesis, that is, the average of the ratios of the number of
false positives to the number of DE genes identified. The
scheme of Benjamini and Hochberg (BH-method) is
applied to adjust p-value in the testing of microarray data
[21,27] (see section "multiple testing").
Simulation studies
The purpose of our simulation study is to determine the
effect of sample size in our model and compare the pro-
posed method with classical statistics for microarray data
analysis. We simulate the expression data with N = 2000
genes and n = 6 replications generated using our model.
Different expression patterns are simulated by adjusting
the element values of  . For example, EE genes are gen-
erated with the same value  ; DE genes are
obtained with different values uniformly sampled from
different intervals to make  . The probability of
differential expression is set to p = 0.05 for the binomial
distribution to select the DE genes.
Microarray data are typically "large N and small n", that is,
the number of samples is much smaller than the number
of genes. Especially with the emergence of replicated
microarray, the number of replication is always discussed
in microarray analysis [9-11]. Multiple testing is always
employed in microarray analysis [30,31]. However, mul-
tiple testing is generally distorted by the dimension curse,
which makes parameter estimates biased with a smaller
number of sample sizes. On the other hand, a larger
number of genes appear to compensate partially for the
destabilizing effect of the sample size, especially for the
estimation of the common parameters of all genes. So we
should explore the effect of the sample size in our meth-
ods. We simulate the replicated measurements with the
previous steps, only changing the number of replication
from n = 2 to 12. Then we estimate the corresponding
parameters of our hierarchical model and calculate the
statistic κg (g = 1,,2000) respectively for the 11 data sets.
Knowing the underlying expression of each gene, we com-
pute several corresponding statistics of error rates, includ-
ing as sensitivity, specificity, positive predict value (PPV)
and negative predict value (NPV), which are defined in
the subsection "Multiple testing" of the section "Meth-
ods", for data sets of different sample sizes. The results are
plotted in Figure 3, where the x-axis represents the
number of replications and the y-axis represents different
error rates. Obviously, the sample size shows little effect
on NPV and specificity but significant effect on PPV and
sensitivity. All of them almost increase and approximate
to stability when the sample sizes increase, so the per-
formance of the method becomes better and better. It is
discovered that the PPV of our testing is significantly
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increased when the sample size n = 4. So in part it is rea-
sonable to select n = 4, as suggested in literature [9].
In the simulation studies, we also compare our methodol-
ogy with existing methods for microarray data analysis,
such as the fold-change, t-test and LNN model. The fold-
change method makes use of direct comparison of inten-
sities, in which the error structure is ignored. The two-
sample t-test overcomes the limitation by assuming the
normality of expression data, but it is affected by the nor-
mality assumption and sample size. The LNN Bayesian
model is developed to address these shortcomings. We
improve the LNN model using the multivariate Bayesian
model by considering the correlation between two meas-
urements of each spot. GLRT is applied to test the hypoth-
eses within the multivariate Bayesian framework.
Flexibility in modelling the correlation between the meas-
urements is a key advantage of the proposed method.
Thus, the expression data can be simulated with different
correlation coefficients. In fact, Figure 3 shows the simu-
lated data for ρ = 0.9. In order to evaluate the perform-
ance, we also simulate two data sets with 0.1 and 0.5.
Knowing the true expression patterns of each gene, we can
calculate the error rates of inference such as sensitivity,
specificity, PPV, NPV and FDR that are defined in the sec-
tion "multiple testing". The results are also shown in
Table 1. In comparison with the good performance of
GLRT, t-test is poor in sensitivity, PPV and FDR. With the
increase of the correlation coefficient ρ, the rates of true
identification of DE in t-test fall from 0.56 to 0.41 and
from 0.67 to 0.57 in the LNN model. On the contrary, the
rate in our model is increased from 0.74 to 0.98. That
implies that the LNN model and the t-test do not perform
well for highly dependent observations. As to the fold-
change method, both sensitivity and FDR are very low and
their ranges are (0.14, 0.31) and (0, 0.03) respectively. In
fact, the number of DE genes identified with fold-change
is reasonably small in comparison with the large number
of genes being tested. The results show that the fold-
change method can be too conservative, that the perform-
ance of t-test can be misleading, and that the identifica-
tion capability of the LNN model is limited especially
when the assumption is deviated.
Results from microarray experiments
Any artificial scenario inevitably is biased regarding the
underlying model and only reflects certain aspects of bio-
logical reality. Therefore, the proposed method is tested in
on two real datasets to verify its performance in real world
applications. The first dataset contains the gene expres-
sion profiles of adenocarcinoma and normal tissues [32].
The data was gathered on the following website http://
microarray.princeton.edu/oncology/carcinoma.html. In
the microarray experiment, n = 18 pairs of colon adeno-
carcinoma and normal colon samples were studied and N
= 7457 cDNAs and ESTs are represented on the oligonu-
cleotide array. We apply our method to the microarray
data to identify the differentially expressed genes in colon
adenocarcinoma. The parameters α and Θ are estimated,
and the estimate of correlation coefficient is   = 0.80.
The GLRT κgs of Equation (8) are calculated for the infer-
ence controlling FDR α = 0.001 and 374 DE genes are
identified using our multivariate Bayesian formulation.
However, in [32] 47 down-regulated and 19 up-regulated
genes in adenocarcinoma are listed whose ratios are more
than 4-fold and p-values associated was also marginally
greater than 0.001. Comparatively, we have discovered
that all 47+19 = 66 genes in [32] are detected with high
confidence using our method. Furthermore, our gene list
also contains many gene products that are related to 66
ˆ ρ
Table 1: Operating characteristics in simulation study of ρ = 0.1, 0.5 and 0.9.
Corr. Coef. Method Sensitivity Specificity PPV NPV FDR
0.1 GLRT 0.742 0.998 0.960 0.987 0.040
LNN 0.667 0.991 0.826 0.980 0.174
t-test 0.557 0.987 0.692 0.978 0.308
fold change 0.309 0.999 0.968 0.966 0.032
0.5 GLRT 0.945 0.998 0.966 0.997 0.034
LNN 0.635 0.986 0.873 0.972 0.127
t-test 0.516 0.968 0.435 0.977 0.565
fold-change 0.252 1 1 0.966 0
0.9 GLRT 0.980 0.999 0.990 0.999 0.010
LNN 0.568 0.988 0.877 0.987 0.123
t-test 0.406 0.972 0.436 0.969 0.564
fold change 0.139 1 1 0.956 0BMC Bioinformatics 2008, 9(Suppl 1):S9 http://www.biomedcentral.com/1471-2105/9/S1/S9
Page 7 of 10
(page number not for citation purposes)
genes in [32], such as Ckshs2, MGSA, matrilysin, and
diverse products related to proliferation and metabolic
rate. Some genes related to guanylin and colon mucosa
antigen are also identified as significant genes with our
model. Therefore, our results include not only the genes
that are already known to be expressed abnormally in
colon cancer, but also other genes confirmed by biological
experiments [32].
The proposed method is also illustrated with another
example of microarray data analysis where the objective is
to identify differentially expressed genes in mouse liver
after treatment with a toxic metal (Cadmium). In our
microarray experiment, n = 6 hybridizations are repeated
for N = 1824 genes and we obtained 6 pairs of red and
green intensity for each gene,   (g  =
1,,1824; i = 1,,6). Data normalization is essential and
we still denote the normalized data with zgi  [33]. As
shown in Figures 1 and 2, the error structure of our micro-
array data depends on the means and correlations
between the intensities measured from different dyes.
Hence we apply the multivariate Bayesian framework to
our microarray data. The parameters α and Θ are esti-
mated, in which the estimate of correlation coefficient is
 = 0.92. Then the GLRT κgs of Equation (8) are calcu-
lated for inference and the BH-method is performed to
adjust the p-values controlling the FDR α = 0.01 in multi-
ple testing. The critical value is calculated to be 10.85,
which means the genes in the following set are inferred as
DE genes
J(α) = {g : λg ≥ κ = 10.85},
Using this criterion, 183 genes are identified. The two-
sample t-test detects 44 specific genes controlling the FDR
= 0.01 while the fold-change only detects 6 genes. In fact,
the above mentioned 6 genes from the fold-change and
44 from the t-test are all included in J(α). Furthermore,
the fold-change does not provide the estimation of the
FDR. We have applied another commonly used approach,
called the significance analysis of microarray (SAM) [11].
When we adjust the parameters especially Δ to detect 183
genes in which 82% belongs to J(α), it gives a higher FDR
about 2.81% than ours. Comparatively, our method pro-
vides a more powerful tool for identification of DE genes
while keeping a lower FDR.
Although the DNA microarray technology is very effective
for understanding alterations in genome-wide patterns of
gene expression, there may be situations in which we need
more evidence to determine which genes are truly differ-
entially expressed from the statistical results and further
biological analysis may be required to verify the candidate
genes. In our study, we also perform another biological
test, the reverse-transcription polymerase chain reaction
(RT-PCR) to confirm the DE genes. We have found that
the relative expression of Ctsc (cathepsin C), Dnase2
(deoxyribonuclease II), Mt-1 (Metallothionein-I) and
A2m (alpha-2-macroglobulin) after the normalization are
up-regulated in triplicate analysis. Based on gene ontology
(GO) analysis http://www.geneontology.org/[34], they
are highly related to the transcriptional regulatory of pro-
stease inhibitor activity (GO: 0030414) and detoxifica-
tion of copper ion (GO:0010273). This implies that there
is a good correlation between the microarray experiment,
RT-PCR, as well as the Bayesian method we have pro-
posed.
Discussion
The DNA microarray technology has important applica-
tions in gene expression data analysis. However, the
potential sources of random and systematic measurement
errors are a critical issue in statistical analysis. It is impos-
sible to propose a statistical model that reflects all sources
of errors. Therefore, a good model should capture the
most essential features of the data. Currently, the Bayesian
methods provide a practical and effective tool for micro-
array analysis. We have explored the multivariate Bayesian
framework to identify DE genes in replicated microarray
experiments. More inherent characteristics of expression
data are accommodated in the proposed model that is
flexible and adaptable to the measurements of each spot.
DE genes can be inferred by the GLRT adjusted by BH-
method controlling the FDR. In comparison with other
methods, the operational characteristics of our method
are better than the intuitive fold change, the t-test and the
LNN model. Furthermore, our method produces lower
FDR and higher efficiency of identification.
Moreover, our model can be extended to the microarray
experiments under multiple conditions beyond control
and treatment. For example, one may be interested in
gene expression of k different dosages of some medicine
with replicated microarray experiments. That is to say, k
measurements are observed from one gene spot. If there
are  N  genes on one chip and n  hybridizations are
repeated, the measurements from one gene spot are writ-
ten as   (g = 1,,N; i = 1,,n). The
corresponding Bayesian model, similar to Equations (1)
and (2) can also be applied to model the expression data,
and only the dimensionality of the feature vectors is k
instead of 2. Besides the global parameter α, the gene-spe-
cific parameters are denoted as
zgi gi
red
gi
green zz = (, ) ’
ˆ ρ
zgi gi gi gi
k zz z = (,,,) ’
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and
As to the inference, the number of hypotheses would
increase significantly with the number of conditions. For
example, there are 5 hypotheses to infer under 3 condi-
tions, equivalent expression, altered expression in one
condition and distinct expression in each condition. Thus,
only some patterns of interest should be tested with the
GLRT calculated on the specific constraints.
With the widespread applications to microarray data anal-
ysis, more sophisticated Bayesian methods are needed to
solve more statistical problems, such as normal assump-
tion, gene independence and parameter estimation. Nor-
mality and independence are regarded as the devices
deducing the probability distribution function, but we
believe more improvement can be made, especially in
terms of dependence.
Conclusions
We have presented a multivariate Bayesian model for dif-
ferential gene expression data analysis. In addition to the
gene-specific variance, this model takes into account the
covariance between the pair of measurements to relax the
constant assumption of correlation coefficient in the com-
mon used hierarchical models. Our model provides a
more realistic and flexible estimate for the variance of
gene expression data under limited replicates. Based on
the multivariate hierarchical model, the multiple GLRT
takes into account the power of gene-specific variance,
latent gene variance and covariance. In our examples
above, the results obtained from our model show better
operating characteristics, especially when the correlation
coefficient of gene expression within one spot is signifi-
cant. This indicates that the power of identification of dif-
ferentially expressed genes can be improved if the
Bayesian model is developed in accordance with the sta-
tistical properties of microarray data.
Methods
Toxic microarray experiment
Cadmium (Cd) is a ubiquitous environmental toxic pol-
lutant with a well established toxicity. Chronic exposure
or even low concentration of Cd has been shown to result
in a variety of pathological disorders such as cancers, ane-
mia, osteoporosis, renal and hepatic dysfunction. A
microarray experiment was designed in the biomedical
laboratory of the department of biology, Hong Kong Bap-
tist University. They explore the genes that are differen-
tially expressed with the toxic treatment, using duel colors
(Cy3 and Cy5) DNA microarray to compare the treatment
group with CdCl2 and control group with NaCl. In our
microarray experiment, eight male adult mice, ICR strain,
were randomly separated into four groups and denoted as
C1T1 and C2T2. In each group one serves as the control
which the other one is for treatment. The mice in control
and treatment group were given a single intraperitoneal
injection of 0.3 ml 0.9% NaCl or the same volume of 2
mg/kg CdCl2 respectively. After 48 hours, mice were sac-
rificed and the livers were collected. Total RNA were
extracted from each liver using the Trizol reagent. The
total RNA samples were reverse transcribed to cDNA in
the presence of fluorescent (Cy3) or (Cy5) dye. Usually,
the treatment group is labelled with Cy3 while the control
group is labelled with Cy5. Probes were then hybridized
onto the UCLA M07 microarray arrays overnight at 65°C.
After two subsequent washings in 2 × SSC, 0.1% SDS and
0.2 × SSC buffer, all the hybridized chips were scanned
using ScanArray 5000 confocal laser scanner (Packard
BioChip BioScience Technology) and images were further
analyzed by the QuantArray Quantitative Microarray
Analysis Software. C1T1 and C2T2 groups were tested in
three individual hybridization experiments and thus 6
hybridized chips are replicated measured. After image
analysis, there is one pair of red and green fluorescence
intensities (after background correction) observed from
each spot, and 6 replicated pairs for each gene. We applied
the logarithm transformation to the measurements as
commonly used in microarray analysis. Before statistical
analysis, the microarray data have to be normalized and
filtered to removing some variation of expression levels in
fluorescence intensities [32]. After data processing, we
denote n replicated pairs of observation component of gth
gene as Zg = (zg1,,zgn)', in which the green and red log-
intensities of gth gene of ith replication is zgi = (xgi, ygi)' (g
= 1,,1824; i = 1,,6).
Lognormal-Normal (LNN) model
The parametric Bayesian model is characterized by mixing
measurements over a latent gene-specific component
π(μg,  ). In the LNN model [26], the measurements xgi
and ygi (g = 1,,N; i = 1,,n) can be expressed in terms of
the observation components following a normal distribu-
tion
and the hierarchical gene-specific components
μ μgg g g k
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2
00 = (,, ,) ’ μμ μ "
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where IG denotes the inverse Gamma (IG) distribution
and μ0, λ0, ν0,   are the hyperparameters. Notice that
the dependence between μg and   is implied with the
conjugate prior π(μg,  ) whose posterior probability has
the same functional form. All measurements xgi and ygi in
this framework are assumed to arise independently and
identically from the same distributional class.
Multiple testing
The error rate in hypothesis testing can be summarized in
Table 2. In the microarray context, the specific N hypoth-
eses is known to be the number of genes on one array; R0
and R1 (R0+R1= N) are observable random variables; N0
and N1 (N0 + N1 = N) are unknown parameters; and others
are unobservable random variables. In general, one would
like to minimize type I errors, false positives (FP), and
type II errors, false negatives (FN) [9,27].
In microarray analysis, the FDR is defined as the expecta-
tion of the ratio of rejected null hypotheses which are
erroneously rejected, that is, the average of the ratio of the
number of false positives to the number of genes identi-
fied as DE. Because of typical large N and small n in micro-
array data, the type I errors increase when many
hypothesis are tested and each test has a specified type I
error probability.
Obviously, it is intuitive to test in the univariate setting to
minimize type II errors rates under the prespecified type I
error rate. As to the case under multiple testing, we have
different procedures. Some definitions about type I error
rate are described, such as FDR, FWER or PCER in [11].
Benjamini and Hochberg's p-value adjustment provided a
more powerful procedure to control FDR [9,11,27,30,31].
Based on the approximate χ2 distribution of κg, we can
apply the method for the significant testing to identify the
DE genes. The algorithm of theBH-method is described as:
Step 1: Order the p-value corresponding to testing N
hypotheses of Hg0 : p(1) ≤ p(2) ≤  p(N).
Step 2: Define the Bonferroni type multiple-testing
, where α is the value of the controlled FDR. Let
m be the largest g to satisfy the inequations.
Step 3: Reject all H(g)0 (g = 1,2,,m), that is to say, genes
indexed by (1), (2),...,(m) might be identified as the DE
genes.
Besides the FDR in the multiple testing, there are other sta-
tistics to assess the significance [9,27]. In microarray data
analysis, sensitivity is defined as the fraction of the true
DE genes correctly identified as DE, i.e. TP/N1; specificity
is defined as the fraction true EE genes correctly identified
as EE, i.e. TN/N0; PPV of Hgk is the fraction of the DE genes
that give a positive result, i.e. TP/R1; and NPV is TN/R0.
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